Literature DB >> 3436320

In vitro activity of ciprofloxacin against methicillin-susceptible and methicillin-resistant staphylococci.

B Gahrn-Hansen1, P Søgaard, M Arpi.   

Abstract

Ciprofloxacin was found to be active against selected strains of methicillin-resistant as well as methicillin-susceptible Staphylococcus aureus and Staphylococcus epidermidis, having minimal inhibitory concentrations less than 0.8 micrograms/ml with inocula of approximately 10(4) CFU/ml. When killing kinetic studies were done with inocula of approximately 10(6) CFU/ml and various ciprofloxacin concentrations, the killing effect was low (less than 3 log10 in 6 h) and regrowth of the culture was seen after 24 h in at least one Staphylococcus aureus strain. After 48 h incubation, mutants with MICs eightfold that of the parental strain had grown to a number of approximately 10(10) CFU/ml.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436320     DOI: 10.1007/BF02014254

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  9 in total

1.  Population analysis of susceptibility to ciprofloxacin and nalidixic acid in Staphylococcus, Pseudomonas aeruginosa, and Enterobacteriaceae.

Authors:  P Søgaard; B Gahrn-Hansen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-10

2.  Ciprofloxacin-resistant Staphylococcus aureus.

Authors:  H Humphreys; E Mulvihill
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

3.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  The in vitro and in vivo activity of ciprofloxacin.

Authors:  H J Zeiler; K Grohe
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  Treatment of infections due to methicillin-resistant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

6.  Vancomycin therapy for methicillin-resistant Staphylococcus aureus.

Authors:  T C Sorrell; D R Packham; S Shanker; M Foldes; R Munro
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.

Authors:  M Arpi; B Gahrn-Hansen; P Søgaard; M W Bentzon
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-04

8.  Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

9.  The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith; R H Eng; E Berman
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

  9 in total
  1 in total

Review 1.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.